Loading clinical trials...
Loading clinical trials...
Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Conditions
Interventions
Seretide Diskus and charcoal
Seretide Diskus
+2 more
Locations
1
Finland
Orion Pharma Clinical Pharmacology Unit
Espoo, Finland
Start Date
January 1, 2013
Primary Completion Date
May 1, 2013
Completion Date
May 1, 2013
Last Updated
January 3, 2014
NCT07219173
NCT07486401
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Orion Corporation, Orion Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions